Achille Marino

Dr. Achille Marino

Pediatric Rheumatology Unit, ASST G. Pini & CTO, Milan, Italy
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Seminars in Arthritis and Rheumatism
Verified
Journal Article
Closed access
AMAchille Marino
Achille Marino
MRMicol Romano
Micol Romano
TGTeresa Giani
Teresa Giani
CGCarla Gaggiano
Carla Gaggiano
SCStefania Costi
Stefania Costi
RCRolando Cimaz
Rolando Cimaz

8 October 2015 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
AMAchille Marino
Achille Marino
PIPagnini Ilaria
Pagnini Ilaria
GTGiani Teresa
Giani Teresa
RCRoberto Caputo
Roberto Caputo
AIArapi Ilir
Arapi Ilir
SGSimonini Gabriele
Simonini Gabriele

5 March 2018 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
AMAchille Marino
Achille Marino
FRFeliciana Real-Fernández
Feliciana Real-Fernández
PRPaolo Rovero
Paolo Rovero
TGTeresa Giani
Teresa Giani
IPIlaria Pagnini
Ilaria Pagnini
GSGabriele Simonini
Gabriele Simonini

1 August 2017 in Pediatric Neurology
Verified
Journal Article
Closed access
AMAchille Marino
Achille Marino
SNSona Narula
Sona Narula
MLMelissa A. Lerman
Melissa A. Lerman

2 July 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
EVErika Valeri
Erika Valeri
SBSara Breggion
Sara Breggion
FBFederica Barzaghi
Federica Barzaghi
MAMonah Abou Alezz
Monah Abou Alezz
GCGiovanni Crivicich
Giovanni Crivicich
AKAnna Kajaste-Rudnitski
Anna Kajaste-Rudnitski
Gain-of-function mutations in STING cause STING-associated vasculopathy with onset in infancy (SAVI) characterized by early-onset systemic inflammation, skin vasculopathy, and interstitial lung disease. Here, we report and characterize a novel STING variant (F269S) identified in a SAVI patient. Single-cell transcriptomics of patient bone marrow revealed spontaneous activation of interferon (IFN) and inflammatory pathways across cell types and a striking prevalence of circulating naïve T cells was observed. Inducible STING F269S expression conferred enhanced signaling through ligand-independent translocation of the protein to the Golgi, protecting cells from viral infections but preventing their efficient immune priming. Additionally, endothelial cell activation was promoted and further exacerbated by cytokine secretion by SAVI immune cells, resulting in inflammation and endothelial damage. Our findings identify STING F269S mutation as a novel pathogenic variant causing SAVI, highlight the importance of the crosstalk between endothelial and immune cells in the context of lung disease, and contribute to a better understanding of how aberrant STING activation can cause pathology.

27 December 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
SCStefania Costi
Stefania Costi
RCRoberto Caporali
Roberto Caporali
AMAchille Marino
Achille Marino
Mucopolysaccharidosis (MPS) is a group of disorders caused by the reduced or absent activity of enzymes involved in the glycosaminoglycans (GAGs) degradation; the consequence is the progressive accumulation of the substrate (dermatan, heparan, keratan or chondroitin sulfate) in the lysosomes of cells belonging to several tissues. The rarity, the broad spectrum of manifestations, the lack of strict genotype-phenotype association, and the progressive nature of MPS make diagnosing this group of conditions challenging. Musculoskeletal involvement represents a common and prominent feature of MPS. Joint and bone abnormalities might be the main clue for diagnosing MPS, especially in attenuated phenotypes; therefore, it is essential to increase the awareness of these conditions among the pediatric rheumatology and orthopedic communities since early diagnosis and treatment are crucial to reduce the disease burden of these patients. Nowadays, enzyme replacement therapy (ERT) and hematopoietic stem cell transplantation (HSCT) are available for some MPS types. We describe the musculoskeletal characteristics of MPS patients through a literature review of MPS cases misdiagnosed as having rheumatologic or orthopedic conditions.